
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $5.6B | $9.7B | $13B | $12.7B | $11.6B | |
Revenue Growth (YoY) | -39.93% | 74.02% | 34.52% | -2.68% | -8.23% | |
Cost of Revenues | $1.8B | $1.9B | $2.2B | $3.1B | $3.8B | |
Gross Profit | $3.7B | $7.8B | $10.8B | $9.5B | $7.9B | |
Gross Profit Margin | 66.85% | 80.66% | 82.72% | 75.28% | 67.73% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $703M | $1.1B | $1.3B | $1.4B | $1.4B | |
Other Inc / (Exp) | -$130M | -$205M | -$20M | -$24M | -$2.5B | |
Operating Expenses | $4.3B | $5.7B | $6.9B | $7.3B | $7.6B | |
Operating Income | -$595M | $2.1B | $3.9B | $2.2B | $269M | |
Net Interest Expenses | $231M | $218M | $250M | $296M | $358M | |
EBT. Incl. Unusual Items | -$956M | $1.7B | $3.6B | $1.9B | -$2.6B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$272M | $425M | $880M | $279M | -$810M | |
Net Income to Company | -$684M | $1.3B | $2.8B | $1.6B | -$1.8B | |
Minority Interest in Earnings | -- | $2M | $8M | -$3M | -$4M | |
Net Income to Common Excl Extra Items | -$684M | $1.3B | $2.8B | $1.6B | -$1.8B | |
Basic EPS (Cont. Ops) | -$9.71 | $19.79 | $58.41 | $42.57 | -$51.23 | |
Diluted EPS (Cont. Ops) | -$9.71 | $19.44 | $57.16 | $42.08 | -$51.23 | |
Weighted Average Basic Share | $70.5M | $64.9M | $47.3M | $38.3M | $35.5M | |
Weighted Average Diluted Share | $70.5M | $66.1M | $48.4M | $38.8M | $35.5M | |
EBITDA | $1.8B | $4.4B | $6.7B | $5.7B | $1.7B | |
EBIT | -$725M | $1.9B | $3.9B | $2.2B | -$2.3B | |
Revenue (Reported) | $5.6B | $9.7B | $13B | $12.7B | $11.6B | |
Operating Income (Reported) | -$595M | $2.1B | $3.9B | $2.2B | $269M | |
Operating Income (Adjusted) | -$725M | $1.9B | $3.9B | $2.2B | -$2.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.4B | $2.7B | $2.8B | $2.5B | $2.1B | |
Revenue Growth (YoY) | -19.44% | 92.47% | 2.63% | -10.51% | -16.56% | |
Cost of Revenues | $378M | $491M | $648M | $836M | $931M | |
Gross Profit | $1B | $2.2B | $2.2B | $1.7B | $1.2B | |
Gross Profit Margin | 73.4% | 82.05% | 76.92% | 66.72% | 55.58% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $182M | $283M | $324M | $325M | $308M | |
Other Inc / (Exp) | -$150M | -$8M | -$2M | -$5M | -$28M | |
Operating Expenses | $1.1B | $1.5B | $1.7B | $1.7B | $1.7B | |
Operating Income | -$39M | $756M | $472M | -$54M | -$552M | |
Net Interest Expenses | $61M | $53M | $73M | $83M | $97M | |
EBT. Incl. Unusual Items | -$250M | $695M | $397M | -$142M | -$677M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$80M | $168M | $85M | -$29M | -$173M | |
Net Income to Company | -$170M | $527M | $312M | -$113M | -$504M | |
Minority Interest in Earnings | -- | $2M | -- | -$1M | -$1M | |
Net Income to Common Excl Extra Items | -$170M | $529M | $312M | -$114M | -$505M | |
Basic EPS (Cont. Ops) | -$2.43 | $9.96 | $7.88 | -$3.21 | -$14.35 | |
Diluted EPS (Cont. Ops) | -$2.43 | $9.71 | $7.72 | -$3.21 | -$14.35 | |
Weighted Average Basic Share | $69.9M | $53.1M | $39.6M | $35.6M | $35.2M | |
Weighted Average Diluted Share | $69.9M | $54.5M | $40.4M | $35.6M | $35.2M | |
EBITDA | $374M | $1.4B | $1.3B | $866M | $431M | |
EBIT | -$189M | $748M | $470M | -$59M | -$580M | |
Revenue (Reported) | $1.4B | $2.7B | $2.8B | $2.5B | $2.1B | |
Operating Income (Reported) | -$39M | $756M | $472M | -$54M | -$552M | |
Operating Income (Adjusted) | -$189M | $748M | $470M | -$59M | -$580M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $5.2B | $11B | $13.1B | $12.4B | $11.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.7B | $2B | $2.4B | $3.3B | $3.8B | |
Gross Profit | $3.5B | $9B | $10.7B | $9.1B | $7.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $634M | $1.2B | $1.4B | $1.4B | $1.3B | |
Other Inc / (Exp) | -$230M | -$63M | -$14M | -$27M | -$2.6B | |
Operating Expenses | $4B | $6.1B | $7.1B | $7.3B | $7.6B | |
Operating Income | -$467M | $2.9B | $3.6B | $1.7B | -$229M | |
Net Interest Expenses | $244M | $210M | $270M | $306M | $372M | |
EBT. Incl. Unusual Items | -$941M | $2.7B | $3.3B | $1.4B | -$3.2B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$245M | $673M | $797M | $165M | -$954M | |
Net Income to Company | -$696M | $2B | $2.5B | $1.2B | -$2.2B | |
Minority Interest in Earnings | -- | $4M | $6M | -$4M | -$4M | |
Net Income to Common Excl Extra Items | -$696M | $2B | $2.5B | $1.2B | -$2.2B | |
Basic EPS (Cont. Ops) | -$9.99 | $33.01 | $56.33 | $32.06 | -$62.93 | |
Diluted EPS (Cont. Ops) | -$10.00 | $32.42 | $55.20 | $31.68 | -$62.95 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.7B | $5.4B | $6.6B | $5.3B | $1.3B | |
EBIT | -$697M | $2.9B | $3.6B | $1.7B | -$2.8B | |
Revenue (Reported) | $5.2B | $11B | $13.1B | $12.4B | $11.2B | |
Operating Income (Reported) | -$467M | $2.9B | $3.6B | $1.7B | -$229M | |
Operating Income (Adjusted) | -$697M | $2.9B | $3.6B | $1.7B | -$2.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.4B | $2.7B | $2.8B | $2.5B | $2.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $378M | $491M | $648M | $836M | $931M | |
Gross Profit | $1B | $2.2B | $2.2B | $1.7B | $1.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $182M | $283M | $324M | $325M | $308M | |
Other Inc / (Exp) | -$150M | -$8M | -$2M | -$5M | -$28M | |
Operating Expenses | $1.1B | $1.5B | $1.7B | $1.7B | $1.7B | |
Operating Income | -$39M | $756M | $472M | -$54M | -$552M | |
Net Interest Expenses | $61M | $53M | $73M | $83M | $97M | |
EBT. Incl. Unusual Items | -$250M | $695M | $397M | -$142M | -$677M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$80M | $168M | $85M | -$29M | -$173M | |
Net Income to Company | -$170M | $527M | $312M | -$113M | -$504M | |
Minority Interest in Earnings | -- | $2M | -- | -$1M | -$1M | |
Net Income to Common Excl Extra Items | -$170M | $529M | $312M | -$114M | -$505M | |
Basic EPS (Cont. Ops) | -$2.43 | $9.96 | $7.88 | -$3.21 | -$14.35 | |
Diluted EPS (Cont. Ops) | -$2.43 | $9.71 | $7.72 | -$3.21 | -$14.35 | |
Weighted Average Basic Share | $69.9M | $53.1M | $39.6M | $35.6M | $35.2M | |
Weighted Average Diluted Share | $69.9M | $54.5M | $40.4M | $35.6M | $35.2M | |
EBITDA | $374M | $1.4B | $1.3B | $866M | $431M | |
EBIT | -$189M | $748M | $470M | -$59M | -$580M | |
Revenue (Reported) | $1.4B | $2.7B | $2.8B | $2.5B | $2.1B | |
Operating Income (Reported) | -$39M | $756M | $472M | -$54M | -$552M | |
Operating Income (Adjusted) | -$189M | $748M | $470M | -$59M | -$580M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $692M | $534M | $570M | $555M | $534M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $647M | $775M | $810M | $900M | $838M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $161M | $205M | $252M | $239M | $239M | |
Other Current Assets | $148M | $95M | $112M | $253M | $236M | |
Total Current Assets | $1.8B | $1.8B | $1.9B | $2.1B | $2B | |
Property Plant And Equipment | $11.1B | $15.6B | $18.6B | $23.9B | $20.8B | |
Long-Term Investments | $667M | $842M | $1.1B | $1.3B | $1.4B | |
Goodwill | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
Other Intangibles | $774M | $724M | $666M | $670M | $601M | |
Other Long-Term Assets | $596M | $636M | $809M | $1.2B | $976M | |
Total Assets | $17.5B | $22.6B | $25.9B | $32.6B | $29B | |
Accounts Payable | $394M | $407M | $466M | $487M | $450M | |
Accrued Expenses | $239M | $411M | $473M | $605M | $564M | |
Current Portion Of Long-Term Debt | $19M | $19M | $27M | $32M | $20M | |
Current Portion Of Capital Lease Obligations | $514M | $496M | $555M | $576M | $628M | |
Other Current Liabilities | $602M | $577M | $619M | $540M | $604M | |
Total Current Liabilities | $2.1B | $2.4B | $2.6B | $2.7B | $2.7B | |
Long-Term Debt | $11B | $15.4B | $18.5B | $23.7B | $22.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $17.7B | $22.8B | $26.6B | $32.9B | $31.4B | |
Common Stock | $1M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -$155M | -$220M | -$703M | -$349M | -$2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $11M | $3M | $6M | $10M | |
Total Equity | -$155M | -$209M | -$700M | -$343M | -$2.3B | |
Total Liabilities and Equity | $17.5B | $22.6B | $25.9B | $32.6B | $29B | |
Cash and Short Terms | $692M | $534M | $570M | $555M | $534M | |
Total Debt | $11.1B | $15.4B | $18.5B | $23.8B | $22.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $576M | $550M | $548M | $522M | $516M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $786M | $779M | $801M | $1B | $873M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $204M | $246M | $274M | $312M | $174M | |
Other Current Assets | $163M | $87M | $161M | $246M | $231M | |
Total Current Assets | $1.9B | $1.8B | $2B | $2.3B | $2B | |
Property Plant And Equipment | $12.1B | $16.8B | $20.1B | $25B | $21.2B | |
Long-Term Investments | $666M | $953M | $1.1B | $1.3B | $1.4B | |
Goodwill | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
Other Intangibles | $750M | $706M | $659M | $658M | $598M | |
Other Long-Term Assets | $465M | $567M | $717M | $949M | $692M | |
Total Assets | $18.6B | $23.6B | $27.4B | $33.5B | $29B | |
Accounts Payable | $458M | $513M | $510M | $504M | $499M | |
Accrued Expenses | $260M | $423M | $476M | $431M | $571M | |
Current Portion Of Long-Term Debt | $19M | $27M | $34M | $405M | $508M | |
Current Portion Of Capital Lease Obligations | $519M | $536M | $533M | $558M | $627M | |
Other Current Liabilities | $569M | $656M | $627M | $651M | $613M | |
Total Current Liabilities | $2.2B | $2.7B | $2.7B | $3.1B | $3.4B | |
Long-Term Debt | $12.1B | $16.8B | $19.4B | $24.2B | $22.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $18.9B | $24.6B | $27.8B | $34B | $31.9B | |
Common Stock | $1M | $1M | $1M | $1M | $1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | $9M | $3M | $7M | $11M | |
Total Equity | -$316M | -$983M | -$441M | -$508M | -$2.8B | |
Total Liabilities and Equity | $18.6B | $23.6B | $27.4B | $33.5B | $29B | |
Cash and Short Terms | $576M | $550M | $548M | $522M | $516M | |
Total Debt | $12.1B | $16.8B | $19.5B | $24.6B | $23.2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$684M | $1.3B | $2.8B | $1.6B | -$1.8B | |
Depreciation & Amoritzation | $2.6B | $2.5B | $2.8B | $3.5B | $4B | |
Stock-Based Compensation | $9M | $30M | $25M | $30M | $19M | |
Change in Accounts Receivable | $115M | -$143M | -$97M | -$43M | $51M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $691M | $3.5B | $4.7B | $3.8B | $3.5B | |
Capital Expenditures | $5.5B | $10.2B | $10.7B | $15.5B | $10.1B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $3.2B | -$6.3B | -$4.3B | -$7.3B | -$2.8B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$355M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $14.5B | $15.6B | $18.1B | $24.9B | $22.9B | |
Long-Term Debt Repaid | -$18.4B | -$11.4B | -$15.2B | -$20B | -$23.5B | |
Repurchase of Common Stock | -$119M | -$1.5B | -$3.3B | -$951M | -$70M | |
Other Financing Activities | -$44M | -$11M | $6M | -$66M | -$72M | |
Cash From Financing | -$4B | $2.7B | -$360M | $3.5B | -$781M | |
Beginning Cash (CF) | $900M | $765M | $626M | $642M | $644M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$177M | -$128M | $48M | -$12M | -$16M | |
Ending Cash (CF) | $765M | $626M | $642M | $644M | $597M | |
Levered Free Cash Flow | -$4.8B | -$6.7B | -$6B | -$11.6B | -$6.5B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $398M | $774M | $436M | $15M | -- | |
Depreciation & Amoritzation | $654M | $667M | $844M | $944M | -- | |
Stock-Based Compensation | $10M | $6M | $8M | $6M | -- | |
Change in Accounts Receivable | -$103M | $67M | -$2M | -$126M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $919M | $1.2B | $963M | $884M | -- | |
Capital Expenditures | $3.2B | $3.6B | $5.1B | $2.9B | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.7B | -$2.7B | -$3.5B | -$1B | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $4.7B | $4.9B | $6.6B | $6.1B | -- | |
Long-Term Debt Repaid | -$2.2B | -$2.9B | -$3.8B | -$5.9B | -- | |
Repurchase of Common Stock | -$3M | -$449M | -$149M | -$1M | -- | |
Other Financing Activities | -$15M | -$12M | -$16M | -$9M | -- | |
Cash From Financing | $2.5B | $1.6B | $2.6B | $139M | -- | |
Beginning Cash (CF) | $639M | $637M | $629M | $599M | -- | |
Foreign Exchange Rate Adjustment | $6M | -$23M | $1M | -$2M | -- | |
Additions / Reductions | $766M | $70M | $52M | -$14M | -- | |
Ending Cash (CF) | $1.4B | $684M | $682M | $583M | -- | |
Levered Free Cash Flow | -$2.3B | -$2.4B | -$4.1B | -$2B | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$696M | $2B | $2.5B | $1.2B | -$2.2B | |
Depreciation & Amoritzation | $2.4B | $2.6B | $3B | $3.6B | $4.1B | |
Stock-Based Compensation | $15M | $32M | $27M | $29M | $18M | |
Change in Accounts Receivable | -$104M | $80M | -$164M | -$151M | $99M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $657M | $4.3B | $4.4B | $3.6B | $3.5B | |
Capital Expenditures | $4.7B | $9.9B | $11.9B | $15.7B | $9.7B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $3.3B | -$6.1B | -$4.8B | -$7.2B | -$2B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $13.5B | $15.7B | $18.7B | $26.9B | $23.1B | |
Long-Term Debt Repaid | -$17.5B | -$11.2B | -$16.1B | -$22B | -$24.6B | |
Repurchase of Common Stock | -$20M | -$2.7B | -$2.1B | -$915M | -$58M | |
Other Financing Activities | -$47M | -$7M | -- | -$99M | -$29M | |
Cash From Financing | -$4.1B | $1.8B | $451M | $3.6B | -$1.6B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$143M | $1M | $17M | -$26M | $18M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$4.1B | -$5.6B | -$7.5B | -$12.1B | -$6.2B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $228M | $1.3B | $748M | -$98M | -$504M | |
Depreciation & Amoritzation | $1.2B | $1.3B | $1.6B | $1.9B | $1B | |
Stock-Based Compensation | $14M | $12M | $16M | $13M | $6M | |
Change in Accounts Receivable | -$159M | $234M | $98M | -$134M | $40M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.3B | $2.4B | $1.8B | $1.5B | $619M | |
Capital Expenditures | $6.2B | $6.3B | $9B | $7B | $3.8B | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$4B | -$3.9B | -$5.2B | -$2.6B | -$715M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $9.3B | $9.7B | $11.9B | $13.3B | $7.4B | |
Long-Term Debt Repaid | -$5.8B | -$6.3B | -$8.2B | -$12.2B | -$7.3B | |
Repurchase of Common Stock | -$22M | -$1.7B | -$200M | -$16M | -$3M | |
Other Financing Activities | -$27M | -$20M | -$30M | -$56M | -$4M | |
Cash From Financing | $3.4B | $1.6B | $3.5B | $1B | $98M | |
Beginning Cash (CF) | $1.4B | $1.3B | $1.3B | $1.2B | $597M | |
Foreign Exchange Rate Adjustment | -$4M | -$25M | $6M | -$15M | $8M | |
Additions / Reductions | $650M | $83M | $34M | -$46M | $2M | |
Ending Cash (CF) | $2.1B | $1.3B | $1.3B | $1.2B | $607M | |
Levered Free Cash Flow | -$5B | -$4B | -$7.2B | -$5.5B | -$3.2B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.